Artificial intelligence disease detection and care coordination platform Viz.ai on Thursday announced an integrated AI solution to help healthcare organizations streamline respiratory care.
The newly announced Viz Pulmonary Suite combines acute and chronic pulmonary workflows into one solution and integrates with electronic health records (EHRs) within the Viz platform. The company says it is the “first comprehensive” AI-driven solution for this kind of care.
Dr. Tim Showalter, Viz.ai’s chief medical officer, told Fierce Healthcare that the studio ensures “the right patient is seen by the right doctor at the right time.”
“This suite includes several features that provide a lot of support to help ensure patients consistently receive appropriate care,” Showalter said. “This includes chart summaries with EHR integration to ensure clinicians have the most accurate information when seeing patients, as well as guideline support for the best next steps.”
The goal of the Viz Pulmonary Suite is to prevent missed diagnoses and delayed treatment of serious lung diseases. It helps treat major lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary nodules, and pulmonary embolism.
Showalter said the new tool includes the ability to “directly identify pulmonary embolism” on scans and identify treatable blood clots. “We have already seen that this reduces hospitalization time and improves survival rates for patients with pulmonary embolism,” he said.
The combination of Viz’s vast scale and EHR integration makes the platform “unique,” according to Showalter.
“We can not only identify patients based on their radiology scans, but we can also quickly understand what is actually going on with that patient and give clinicians the information they need to take quick action to provide appropriate treatment,” Showalter said.
In late March, the company also rolled out Viz Agent Studio. The company says it is the first agent platform for health systems to build and deploy their own customizable care pathways.
The tool allows healthcare organizations to transform clinical guidelines into workflows that can be deployed and scaled “throughout the enterprise using natural language,” executives said.
Since the company’s launch in 2016, its platform has been deployed in 2,000 hospitals across the country, covering “two-thirds” of the country’s population, CEO and co-founder Chris Mansi, MD, told Fierce Healthcare.
